The role of Glu192 in the allosteric control of the S2′ and S3′ subsites of thrombin

被引:20
作者
Marque, PE
Spuntarelli, R
Juliano, L
Aiach, M
Le Bonniec, BF
机构
[1] Univ Paris 05, INSERM, Fac Pharm, F-75270 Paris 06, France
[2] Escola Paulista Med, Dept Biofis, BR-04044020 Sao Paulo, SP, Brazil
关键词
D O I
10.1074/jbc.275.2.809
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Thrombin is an allosteric protease controlled through exosites flanking the catalytic groove. Binding of a peptide derived from hirudin (Hir(52-65)) and/or of heparin to these opposing exosites alters catalysis, We have investigated the contribution of subsites S-2' and S-3' to this allosteric transition by comparing the hydrolysis of two sets of fluorescence-quenched substrates having all natural amino acids at positions P-2' and P-3'. Regardless of the amino acids, Hir(52-65) decreased, and heparin increased the k(cat)/K-m value of hydrolysis by thrombin. Several lines of evidence have suggested that Glu(192) participates in this modulation. We have examined the role of Glu(192) by comparing the catalytic activity of thrombin and its E192Q mutant. Mutation substantially diminishes the selectivity of thrombin, The substrate with the "best" P-2' residue was cleaved with a k(cat)/K-m value only 49 times higher than the one having the "least favorable" P-2' residue (versus 636-fold with thrombin). Mutant E192Q also lost the strong preference of thrombin for positively charged P-3' residues and its strong aversion for negatively charged P-3' residues. Furthermore, both Hir(52-65) and heparin increased the k(cat)/K-m value of substrate hydrolysis. We conclude that Glu(192) is critical for the P-2' and P-3' specificities of thrombin and for the allostery mediated through exosite 1.
引用
收藏
页码:809 / 816
页数:8
相关论文
共 67 条
[1]   STRUCTURES OF THE NONCOVALENT COMPLEXES OF HUMAN AND BOVINE PROTHROMBIN FRAGMENT-2 WITH HUMAN PPACK-THROMBIN [J].
ARNI, RK ;
PADMANABHAN, K ;
PADMANABHAN, KP ;
WU, TP ;
TULINSKY, A .
BIOCHEMISTRY, 1993, 32 (18) :4727-4737
[2]   Bothrojaracin: A potent two-site-directed thrombin inhibitor [J].
Arocas, V ;
Zingali, RB ;
Guillin, MC ;
Bon, C ;
JandrotPerrus, M .
BIOCHEMISTRY, 1996, 35 (28) :9083-9089
[3]   TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex [J].
Bajzar, L ;
Morser, J ;
Nesheim, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) :16603-16608
[4]   Exosites 1 and 2 are essential for protection of fibrin-bound thrombin from heparin-catalyzed inhibition by antithrombin and heparin cofactor II [J].
Becker, DL ;
Fredenburgh, JC ;
Stafford, AR ;
Weitz, JI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (10) :6226-6233
[5]  
BOCK PE, 1992, J BIOL CHEM, V267, P14974
[6]  
BODE W, 1992, PROTEIN SCI, V1, P426
[7]   LATE-FIBRIN(OGEN) FRAGMENT-E MODULATES HUMAN ALPHA-THROMBIN SPECIFICITY [J].
BOUTON, MC ;
JANDROTPERRUS, M ;
BEZEAUD, A ;
GUILLIN, MC .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 215 (01) :143-149
[8]   ROLE OF THE THROMBIN INSERTION LOOP-144-155 - STUDY OF THROMBIN MUTATIONS W148G, K154E AND A THROMBIN-BASED SYNTHETIC PEPTIDE [J].
BOUTON, MC ;
PLANTIER, JL ;
DEMBAK, M ;
GUILLIN, MC ;
RABIET, MJ ;
JANDROTPERRUS, M .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 229 (02) :526-532
[9]   Characteristics of the interaction between thrombin exosite 1 and the sequence 269-297 of platelet glycoprotein Ibα [J].
Bouton, MC ;
Thurieau, C ;
Guillin, MC ;
Jandrot-Perrus, M .
THROMBOSIS AND HAEMOSTASIS, 1998, 80 (02) :310-315
[10]   Allosteric effects of a monoclonal antibody against thrombin exosite II [J].
Colwell, NS ;
Blinder, MA ;
Tsiang, M ;
Gibbs, CS ;
Bock, PE ;
Tollefsen, DM .
BIOCHEMISTRY, 1998, 37 (43) :15057-15065